Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy.

@article{Pencharz2018TheranosticsIN,
  title={Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy.},
  author={Deborah Pencharz and Gopinath Gnanasegaran and Shaunak Navalkissoor},
  journal={The British journal of radiology},
  year={2018},
  volume={91 1091},
  pages={
          20180108
        }
}
Theranostics and its principles: pre-treatment selection of patients who are most likely to benefit from treatment by the use of a related, specific diagnostic test are integral to the treatment of patients with neuroendocrine tumours (NETs). This is due to NETs' important, but variable, somatostatin receptor (SSTR) expression, their heterogeneity and variation in site of primary and rate of progression. Only patients whose tumours have sufficient expression of SSTRs will benefit from SSTR… CONTINUE READING